NewAmsterdam Pharma (NAMS) News Today $22.20 +0.22 (+1.00%) Closing price 07/18/2025 04:00 PM EasternExtended Trading$22.20 +0.00 (+0.02%) As of 07/18/2025 05:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NAMS Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Atle Fund Management AB Cuts Stock Holdings in NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS)4 hours ago | marketbeat.comNewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Shares Sold by Jennison Associates LLCJuly 19 at 7:30 AM | marketbeat.comNewAmsterdam Pharma (NASDAQ:NAMS) Earns Neutral Rating from Analysts at The Goldman Sachs GroupJuly 19 at 2:01 AM | americanbankingnews.comNewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) COO Sells $1,019,879.36 in StockJuly 18 at 9:54 PM | marketbeat.comInsider Selling: NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) COO Sells 51,043 Shares of StockJuly 18 at 9:53 PM | marketbeat.comDouglas F. Kling Sells 47,569 Shares of NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) StockJuly 18 at 9:35 AM | insidertrades.comGoldman Sachs Initiates Coverage of NewAmsterdam Pharma Company N.V. (NAMS) with Neutral RecommendationJuly 17 at 2:34 PM | msn.comNewAmsterdam Pharma (NASDAQ:NAMS) Coverage Initiated at The Goldman Sachs GroupJuly 17 at 8:10 AM | marketbeat.comJefferies Remains Bullish on NewAmsterdam Pharma (NAMS)July 16 at 6:27 PM | msn.comNewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Receives Average Recommendation of "Buy" from AnalystsJuly 14, 2025 | americanbankingnews.comNewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Receives Average Rating of "Buy" from AnalystsJuly 14, 2025 | marketbeat.comNewAmsterdam Pharma (NASDAQ:NAMS) Trading Up 5.7% - Still a Buy?July 9, 2025 | marketbeat.comNewAmsterdam Pharma (NASDAQ:NAMS) Stock Rating Upgraded by Wall Street ZenJuly 5, 2025 | marketbeat.comNewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Director James N. Topper Purchases 1,260 SharesJune 27, 2025 | insidertrades.comNewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Director James N. Topper Purchases 1,260 SharesJune 26, 2025 | marketbeat.comNewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Director James N. Topper Buys 2,520 SharesJune 26, 2025 | marketbeat.comFirst Week of February 2026 Options Trading For NewAmsterdam Pharma (NAMS) - NasdaqJune 24, 2025 | nasdaq.comNewAmsterdam Pharma Company N.V. (NAMS) - Yahoo FinanceJune 24, 2025 | finance.yahoo.comNewAmsterdam Pharma (NASDAQ:NAMS) Downgraded by Wall Street Zen to "Sell"June 21, 2025 | marketbeat.comNewAmsterdam Pharma (NASDAQ:NAMS) Shares Gap Up - Time to Buy?June 20, 2025 | marketbeat.comJames N. Topper Acquires 8,584 Shares of NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) StockJune 19, 2025 | insidertrades.comNewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Given Average Rating of "Buy" by AnalystsJune 19, 2025 | marketbeat.comCiti initiates NewAmsterdam Pharma stock with buy rating on cholesterol drugJune 18, 2025 | investing.comJames N. Topper Purchases 8,584 Shares of NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) StockJune 18, 2025 | marketbeat.comInsider Selling: NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) COO Sells 100,000 Shares of StockJune 18, 2025 | marketbeat.comNewAmsterdam Pharma (NASDAQ:NAMS) Earns Buy Rating from Analysts at CitigroupJune 17, 2025 | marketbeat.comNewAmsterdam Pharma (NASDAQ:NAMS) Shares Purchased by Handelsbanken Fonder ABJune 13, 2025 | marketbeat.com5NAMS : What Analysts Are Saying About NewAmsterdam Pharma...June 12, 2025 | benzinga.comNewAmsterdam Pharma (NASDAQ:NAMS) Given Buy Rating at Needham & Company LLCJune 12, 2025 | marketbeat.comStifel Initiates Coverage of NewAmsterdam Pharma Company N.V. (NAMS) with Buy RecommendationJune 11, 2025 | msn.comNewAmsterdam Pharma Company N.V. (NAMS) Initiated with a Buy at StifelJune 11, 2025 | insidermonkey.comNewAmsterdam Pharma Rings the Closing BellJune 11, 2025 | nasdaq.comNewAmsterdam Pharma (NASDAQ:NAMS) Shares Down 4.4% - Should You Sell?June 11, 2025 | marketbeat.comNewAmsterdam Pharma Schedules R&D Day for June 2025June 11, 2025 | tipranks.comNewAmsterdam Pharma (NASDAQ:NAMS) Trading 7.5% Higher - Should You Buy?June 10, 2025 | marketbeat.comAnalysts Have Just Cut Their NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Revenue Estimates By 14%June 10, 2025 | finance.yahoo.comAnalysts Offer Predictions for NAMS FY2026 EarningsJune 10, 2025 | marketbeat.comNewAmsterdam Pharma (NASDAQ:NAMS) Now Covered by Stifel NicolausJune 10, 2025 | marketbeat.comNewAmsterdam Pharma Shares Rise on Positive Alzheimer's Cholesterol Treatment DataJune 10, 2025 | marketwatch.comNewAmsterdam Pharma Announces Positive Topline Alzheimer’s Disease Data from BROADWAY Clinical TrialJune 10, 2025 | finance.yahoo.comStifel Initiates Coverage on NewAmsterdam Pharma (NAMS) with Positive Outlook | NAMS Stock NewsJune 9, 2025 | gurufocus.comNewAmsterdam Pharma (NASDAQ:NAMS) Shares Gap Up - Here's What HappenedJune 9, 2025 | marketbeat.comPromising Alzheimer’s Drug Development Fuels Buy Rating for NewAmsterdam PharmaJune 9, 2025 | tipranks.comNewAmsterdam Pharma (NAMS) Reveals Alzheimer's Biomarker Data from Key Trial | NAMS Stock NewsJune 9, 2025 | gurufocus.comNewAmsterdam Pharma Announces Positive Topline Alzheimer's Disease Data from BROADWAY Clinical TrialJune 9, 2025 | gurufocus.comNewAmsterdam Pharma Co NV (NAMS) Announces Promising Phase 3 Trial Results for Alzheimer's ...June 9, 2025 | gurufocus.comNewAmsterdam Pharma Announces Positive Topline Alzheimer's Disease Data from BROADWAY Clinical ...June 9, 2025 | gurufocus.comNewAmsterdam Pharma Announces Positive Topline Alzheimer's Disease Data from BROADWAY Clinical TrialJune 9, 2025 | globenewswire.comBank of America Corp DE Grows Stock Position in NewAmsterdam Pharma (NASDAQ:NAMS)June 7, 2025 | marketbeat.comNewAmsterdam Pharma to Host R&D Day on June 11, 2025June 5, 2025 | globenewswire.com Get NewAmsterdam Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for NAMS and its competitors with MarketBeat's FREE daily newsletter. Email Address NAMS Media Mentions By Week NAMS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NAMS News Sentiment▼0.340.57▲Average Medical News Sentiment NAMS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NAMS Articles This Week▼136▲NAMS Articles Average Week Get NewAmsterdam Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for NAMS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BridgeBio Pharma News Blueprint Medicines News Verona Pharma PLC American Depositary Share News Roivant Sciences News Elanco Animal Health News Revolution Medicines News Legend Biotech News Grifols News TG Therapeutics News Nuvalent News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NAMS) was last updated on 7/19/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredI warned you about Nvidia… now look what’s happeningNvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before t...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NewAmsterdam Pharma Company N.V. Please log in to your account or sign up in order to add this asset to your watchlist. Share NewAmsterdam Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
